Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04774913
Other study ID # 195282
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 8, 2021
Est. completion date April 2027

Study information

Verified date February 2023
Source Haukeland University Hospital
Contact Anja Øksnes, MD
Phone +4755975000
Email anao@helse-bergen.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Following unsuccessful CTO crossing a CTO modification procedure is sometimes performed. CTO PCI registries where plaque modification has been performed in some patients, report this to be safe, and associated with higher success rates at subsequent attempts. It has never been investigated whether a planned investment procedure, with an intention that both the initial and staged completion PCI are of shorter duration, could improve safety and efficacy. The investigators hypothesize that 1. A planned investment procedure in the treatment of CTOs will be associated with improved patient safety 2. A planned investment procedure will be associated with improved cumulative procedure success rates 3. A planned two stage procedure will be associated with improved patient experience


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date April 2027
Est. primary completion date April 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Ability to provide written informed consent - Comply with the procedural and study follow-up schedule - Planned CTO PCI in accordance with the European and American appropriateness criteria. - CTO defined as high-risk Exclusion Criteria: - Non-high risk CTO - Occlusion within a stent - Flush aorto-ostial occlusion of RCA and Left Main (LMS) - Limited arterial access precluding repeat procedure - Baseline non invasive testing showing non-viable target vessel territory - Contra-indication to dual antiplatelet therapy - Pregnancy - Prior radiation skin injury - Lack of informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)
CTO PCI completed as a two step procedure with an initial planned CTO modification and a completion procedure after 8-12 weeks

Locations

Country Name City State
Norway Haukeland University Hospital Bergen
United Kingdom Golden Jubilee National Hospital Glasgow
United States Columbia University Medical Center/ NewYork Presbyterian Hospital New York New York

Sponsors (2)

Lead Sponsor Collaborator
Haukeland University Hospital Golden Jubilee National Hospital

Countries where clinical trial is conducted

United States,  Norway,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness CTO PCI Procedural success, Complete technical success plus the absence of an in-hospital major adverse cardiovascular event (MACE; death, MI, or clinically driven target vessel revascularization [TVR] Up to 12 weeks
Primary Compositie safety endpoint Death, myocardial infarction and procedural related complications 30 days post procedure
Secondary CTO PCI technical success Technical success is restoration of TIMI >=2 antegrade flow with <30% residual diameter stenosis within the CTO segment At the end of staged CTO PCI completion procedure and within 3 months
Secondary CTO PCI investment procedural success Investment complete technical success 30 days post procedure
Secondary Composite Clinical endpoint Cardiac death, MI , cardiovascular hospitalization and target vessel revascularization. 30 days, 3 & 12 months
Secondary European Quality of Life-5 Dimensions 5 item measure of mobility, self-care, usual activity, pain or discomfort, and anxiety or depression . Score 0-100, where high score better. Baseline, 3 and 12 months
Secondary Seattle angina questionnaire (SAQ7) 3 domain score of physical limitation (SAQ7-PL), angina frequency (SAQ7-AF) and quality of life (SAQ7-QL). Score 0-100, where high score better. Baseline, 3 & 12 months
Secondary Patient related outcome measures (PROM) Qualitative interviews Through study completion, an average of 15 months.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A